Hepatic Tumor
9
0
0
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
11.1%
1 terminated out of 9 trials
85.7%
-0.8% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (9)
A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas
MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors
A Pilot Study of Thermodox and MR-HIFU for Treatment of Relapsed Solid Tumors
Butorphanol in Pain Following Ablation for Hepatic Tumor
A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors
Evaluation of the Reproducibility of Ablation Volumes at One Month After Microwave Treatment Compared to the Manufacturer's Abacus: on the Kidney, Liver and Lung
Multicenter Study to Evaluate a New Robotic Device for Image-guided Percutaneous Needle Placement
Robotic Endomicroscopy to Better Define Resection Strategies Applied to Hepatic Surgery
Impact of New Interventional Imaging Modality Use on Patient Radiation Exposure in Transarterial Chemoembolization